Eli Lilly said on Monday it plans to build a new $3 billion manufacturing plant in the Netherlands to expand the production ...
Among the medicines to be produced at the site will be orforglipron, the company’s oral small-molecule GLP-1 receptor agonist ...
The new $3 billion manufacturing facility will be sited at the Leiden Bio Science Park in Katwijk, and will be Lilly's first ...
Eli Lilly and Company (NYSE: LLY) announced today plans to build a new $3 billion manufacturing facility in Katwijk, the ...
Trump administration pressure on Big Pharma to focus investment on the US has raised concerns in Europe, and specifically the ...
The support is broad to encourage institutions to consider how to address AI-related challenges and opportunities in ways ...
US pharma group says region’s use of ‘one-way insurance system’ to keep down prices is not fair on the industry ...
Lilly, an Indianapolis-based drugmaker, plans to build a $3 billion manufacturing plant in the Netherlands to boost ...
Biotech Viking Therapeutics has gained prominence over the past two years, but it could have plenty of upside left.
Eli Lilly And Company (($LLY)) announced an update on their ongoing clinical study. Study Overview: Eli Lilly and Company is ...
Along with the company’s investment plans in Puerto Rico, Lilly also announced plans to build a $5 billon manufacturing plant ...
Port Angeles’ Lilly Anne Lancaster is getting hot for the Roughriders at the right time of year. Lancaster scored a hat trick ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results